CI Global Healthcare Leaders Index ETFCBOE Canada:CHCL.B
- LAST PRICE21.94
- TODAY'S CHANGE (%)0.00 (0.00%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.00 / 21.94
- Day Range---
- 52 Week Range
- Volume---
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CHCL.B |
|---|---|---|
| 12:12 ET | 8000 | 22.01 |
| 02:08 ET | 52300 | 22.03 |
| 03:59 ET | 0 | 22 |
| US Equity | 73.1% |
|---|---|
| Int'l Equity | 26.8% |
| Cash | 0.1% |
| CDN Equity | 0 |
| Fixed Income | 0 |
| Other | 0 |
| Healthcare | 99.2% |
|---|---|
| Consumer Defensive | 0.4% |
| Industrials | 0.3% |
| Technology | 0.1% |
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Real Estate | 0 |
| Utilities | 0 |
| United States | 73.2% |
|---|---|
| Asia/Oceania | 6.0% |
| Europe | 4.1% |
| Africa | 0 |
| Latin America | 0 |
| Canada | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 8.3% | -7.25% | $23.0M |
UnitedHealth Group Inc | Long | 5.8% | -7.26% | $16.0M |
Novo Nordisk A/S Class B | Long | 5.1% | -7.64% | $14.2M |
Johnson & Johnson | Long | 4.8% | -7.26% | $13.3M |
Merck & Co Inc | Long | 4.2% | -7.26% | $11.7M |
AbbVie Inc | Long | 4.1% | -7.25% | $11.2M |
Thermo Fisher Scientific Inc | Long | 2.8% | -7.23% | $7.8M |
AstraZeneca PLC | Long | 2.6% | -7.64% | $7.1M |
Abbott Laboratories | Long | 2.5% | -7.26% | $6.9M |
Novartis AG Registered Shares | Long | 2.5% | -7.64% | $6.8M |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | CI Global Asset Management |
Inception | August 12, 2021 |
CHCL seeks to replicate, to the extent reasonably possible, the performance of a global healthcare index, net of expenses. Currently, CHCL seeks to replicate the performance of the Solactive Developed Markets Healthcare 150 CAD Index (CA NTR) (the “Indexâ€). The Index intends to track the performance of the largest 150 companies from the global healthcare industry.
| Total Net Assets | $276.6M |
|---|---|
| Shares Out. | 11.4M |
| Net Asset Value (NAV) | $22.00 |
| Prem/Discount to NAV | -0.02% |
| P/E Ratio | 30.5 |
| Dividend Yield | 1.10% |
| Dividend per Share | 0.24 CAD |
| Ex-Dividend Date | 03/21/2024 |
| Dividend Payment Date | 03/28/2024 |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Large Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.35% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.38% |